StockTipsArenaBeta

BUY Emcure Pharmaceuticals Limited — BOB Capital Markets

BUYEmcure Pharmaceuticals Limited
Emcure Pharmaceuticals share price target & all analyst calls

byBOB Capital MarketsHorizon: NA (inferred 1 year)5 Feb 2026via Institutional / Brokerage Research

Entry₹1,482.3Inferred
Target₹1,787
Total upside +20.56% (call closed)
Stop lossNot given
Exit₹1,7874 May 2026, 12:05 pm
Target hit+20.56%0.00%upside left
Follow BOB Capital Markets for new calls(63% target hit, 357 closed calls)Get alertsWatch EMCURE for new buy/sell callsGet alertsSee 6 active Long-term calls on EMCURESee 214 active Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 23 Oct, 12:35 am IST
1 supporting0 opposing
Supports the BUY call (1)

1 advisor has an active short-term BUY call on this stock

Advisor consensus · adjacent horizon·15 Apr · 3w ago

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Emcure Pharmaceuticals

All analyst calls on Emcure Pharmaceuticals

More from BOB Capital Markets

Every call and its outcome